Characteristics and prognosis of patients requiring valve surgery during active infective endocarditis

Journal of Heart Valve Disease

Volumn 20, Issue 2, 2011, Pages 223-228

  Fayad, Georges ^a   Leroy, Guillaume ^b   Devos, Patrick ^a   Hervieux, Erik ^a   Senneville, Eric ^b   Koussa, Mohamad ^a   Leroy, Olivier ^b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b CENTRE HOSPITALIER DE TOURCOING   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC THERAPY; AORTA VALVE; ARTICLE; ASPERGILLUS; BACTERIAL ENDOCARDITIS; CANDIDA; COAGULASE NEGATIVE STAPHYLOCOCCUS; CORYNEBACTERIUM; ENTEROCOCCUS; FEMALE; HAEMOPHILUS INFLUENZAE; HEART VALVE SURGERY; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MITRAL VALVE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROPIONIBACTERIUM; PROSTHETIC VALVE DYSFUNCTION; PROSTHETIC VALVE ENDOCARDITIS; PULMONARY VALVE; RETROSPECTIVE STUDY; STAPHYLOCOCCUS; STREPTOCOCCUS; SURGICAL MORTALITY; TRICUSPID VALVE; AGED; CHI SQUARE DISTRIBUTION; FRANCE; HEART SURGERY; HEART VALVE; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; INFECTION; INSTRUMENTATION; MICROBIOLOGY; MIDDLE AGED; MORTALITY; REOPERATION; RISK; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; SURVIVAL; TIME; TREATMENT OUTCOME; VALVULAR HEART DISEASE;

ADULT; AGED; ANTI-INFECTIVE AGENTS; CARDIAC SURGICAL PROCEDURES; CHI-SQUARE DISTRIBUTION; ENDOCARDITIS, BACTERIAL; FEMALE; FRANCE; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEART VALVES; HOSPITAL MORTALITY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PROSTHESIS-RELATED INFECTIONS; REOPERATION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 79957720187     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Cabell CH, Abrutyn E, Fowler VG, Jr., et al.; The International Collaboration on Endocarditis Merged Database (ICE-MD) Study Group Investigators. Use of surgery in patients with native valve infective endocarditis: Results from the International Collaboration on Endocarditis Merged Database. Am Heart J 2005;150:1092-1098
2. Wang A, Pappas P, Anstrom KJ, et al.; The International Collaboration on Endocarditis Investigators. The use and effect of surgical therapy for prosthetic valve infective endocarditis: A propensity analysis of a multicenter, international cohort. Am Heart J 2005;150:1086-1091
3. Ruttmann E, Legit C, Poelzl G, et al. Mitral valve repair provides improved outcome over replacement in active infective endocarditis. J Thorac Cardiovasc Surg 2005;130:765-771
4. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: A risk factor for hospital mortality among critically ill patients. Chest 1999;115:462-474
5. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000;118:146-155
6. Petrak RM, Sexton DJ, Butera ML, et al. The value of an infectious diseases specialist. Clin Infect Dis 2003;36:1013-1017
7. Esposito S, Leone S. Antimicrobial treatment for Intensive Care Unit (ICU) infections including the role of the infectious disease specialist. Int J Antimicrob Agents 2007;29:494-500
8. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30:633-638
9. Jault F, Gandjbakhch I, Rama A, et al. Active native valve endocarditis: Determinants of operative death and late mortality. Ann Thorac Surg 1997;63:1737-1741
10. Mouly S, Ruimy R, Launay O, et al. The changing clinical aspects of infective endocarditis: Descriptive review of 90 episodes in a French teaching hospital and risk factors for death. J Infect 2002;45:246-256
11. Alexiou C, Langley SM, Stafford H, Lowes JA, Livesey SA, Monro JL. Surgery for active culturepositive endocarditis: Determinants of early and late outcome. Ann Thorac Surg 2000;69:1448-1454
12. Olaison L, Pettersson G. Current best practices and guidelines indications for surgical intervention in infective endocarditis. Infect Dis Clin North Am 2002;16:453-475
13. Tleyjeh IM, Ghomrawi HM, Steckelberg JM, et al. The impact of valve surgery on 6-month mortality in left-sided infective endocarditis. Circulation 2007;115:1721-1728
14. .Vikram HR, Buenconsejo J, Hasbun R, Quagliarello VJ. Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis: A propensity analysis. J Am Med Assoc 2003;290:3207-3014
15. Aksoy O, Sexton DJ, Wang A, et al. Early surgery in patients with infective endocarditis: A propensity score analysis. Clin Infect Dis 2007;44:364-372
16. Murdoch DR, Corey GR, Hoen B, et al.; The International Collaboration on Endocarditis- Prospective Cohort Study (ICE-PCS) Investigators. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: The International Collaboration on Endocarditis- Prospective Cohort Study. Arch Intern Med 2009;169:463-473
17. Lalani T, Cabell CH, Benjamin DK, et al.; The International Collaboration on Endocarditis- Prospective Cohort Study (ICE-PCS) Investigators. Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: Use of propensity score and instrumental variable methods to adjust for treatment-selection bias. Circulation 2010;121:1005-1013
18. Thuny F, Beurtheret S, Gariboldi V, et al. Outcome after surgical treatment performed within the first week of antimicrobial therapy during infective endocarditis: A prospective study. Arch Cardiovasc Dis 2008;101:687-695
19. Nadji G, Goissen T, Brahim A, Coviaux F, Lorgeron N, Tribouilloy C. Impact of early surgery on 6- month outcome in acute infective endocarditis. Int J Cardiol 2008;129:227-232
20. Revilla A, López J, Vilacosta I, et al. Clinical and prognostic profile of patients with infective endocarditis who need urgent surgery. Eur Heart J 2007;28:65-71
21. Musci M, Siniawski H, Pasic M, et al. Surgical therapy in patients with active infective endocarditis: Seven-year single centre experience in a subgroup of 255 patients treated with the Shelhigh stentless bioprosthesis. Eur J Cardiothorac Surg 2008;34: 410-417
22. Rekik S, Trabelsi I, Maaloul I, et al. Short- and longterm outcomes of surgery for active infective endocarditis: A Tunisian experience. Interact Cardiovasc Thorac Surg 2009;9:241-245
23. David TE, Gavra G, Feindel CM, Regesta T, Armstrong S, Maganti MD. Surgical treatment of active infective endocarditis: A continued challenge. J Thorac Cardiovasc Surg 2007;133:144-149
24. Jassal DS, Neilan TG, Pradhan AD, et al. Surgical management of infective endocarditis: Early predictors of short-term morbidity and mortality. Ann Thorac Surg 2006;82:524-529
25. Edwards MB, Ratnatunga CP, Dore CJ, Taylor KM. Thirty-day mortality and long-term survival following surgery for prosthetic endocarditis: A study from the UK heart valve registry. Eur J Cardiothorac Surg 1998;14:156-164